Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
The New York Institute Of Technology currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, DHARITHREESAN, NIDHI. Prosecution is confined to a distinct art unit, reflecting a narrow technical focus for the current application. DHARITHREESAN, NIDHI is the busiest examiner, managing the busiest examiner pending action.
Having a distinct examiner and a distinct art unit indicates a streamlined but centralized prosecution process for the portfolio. This specific technical focus in a distinct art unit may lead to a more predictable examination timeline. The pending office action is the only active matter currently being reviewed by the assigned examiner for this institute.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DHARITHREESAN, NIDHI | 1 | 39.6% | +36.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17058165 | METHOD AND SYSTEM FOR USE IN DIRECT SEQUENCING OF RNA | DHARITHREESAN, NIDHI | 41d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17058165 | METHOD AND SYSTEM FOR USE IN DIRECT SEQUENCING OF RNA | DHARITHREESAN, NIDHI | 41d |
| Art Unit | Apps |
|---|---|
| 1686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17058165 | METHOD AND SYSTEM FOR USE IN DIRECT SEQUENCING OF RNA | DHARITHREESAN, NIDHI | 1686 | §102§103§112 | Non-Final OA | 41d | Pending | Nov 24, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial